Skip to main content
. 2018 Dec 21;4(4):541–550. doi: 10.1016/j.ekir.2018.12.011

Table 2.

Comparison of cytokine levels in blood samples with and without AT1R-Ab and HLA DSA

Cytokine HLA DSA– AT1R-Ab– (n = 126) HLA DSA– AT1R-Ab+ (n = 81) HLA DSA+ AT1R-Ab– (n = 14) HLA DSA+ AT1R-Ab+ (n = 11) P
pg/ml Median (IQR) Median (IQR) Median (IQR) Median (IQR)
TNF-α 8.8 (5.76–14.4) 11.11 (7.83–16.56) 7.8 (5.15–8.48) 20.44 (5.33–43.05) 0.023
IFN-γ 3.57 (0.29–11.37) 8.52 (4.07–19.84) 5.88 (0.92–17.5) 4.13 (0.58–13.35) 0.006
IL-8 6.11 (2.06–16.72) 19.94 (7.67–46.56) 7.03 (0.18–41.75) 10.22 (4.46–65.69) <0.001
% >LLD n (%) n (%) n (%) n (%)
IL-1β 34 (26.98) 44 (54.32) 5 (35.71) 3 (27.27) 0.001
IL-6 32 (25.4) 34 (41.98) 4 (28.57) 5 (45.45) 0.069
IL-17 26 (20.63) 21 (25.93) 2 (14.29) 5 (45.45) 0.249

AT1R-Ab, angiotensin II type 1 receptor antibody; HLA DSA, human leukocyte antigen donor-specific antibodies; IFN, interferon; IL, interleukin; IQR, interquartile range; TNF, tumor necrosis factor.

For cytokines with <50% of samples above the lower limit of detection (LLD) (TNF-α, IFN-γ, IL-8) data are summarized as median and IQR and compared using the Kruskal-Wallis test. For cytokines in which ≥50% of samples were below the LLD (IL-1β, IL-6, IL-17) data are summarized as percent positive where positive is >LLD and compared using χ2 test. The comparison of all 4 groups was statistically significant for all cytokines except IL-6 and IL-17.